Latest Breaking News On - King british heart foundation centre - Page 1 : comparemela.com

Galectin-3-binding protein (LGALS3BP) could be a new therapeutic anti-viral target for treating COVID-19.

United kingdomCity ofManuel mayrShankar hariKing college londonBritish heart foundation professorNature communicationsYour healthKing british heart foundation centreKing college hospitalsCollege londonBritish heart foundationAntivirals taskforceManu shankar hariCritical care medicineBritish heart foundation centre